Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Elna Van Pletzen

The Council of the University of the Free State (UFS) is seeking to co-opt a suitable candidate to serve for a period of four (4) years on the Finance Committee of Council. To this end, nominations for suitably qualified and experienced candidates are invited.

The Finance Committee of Council exercises oversight over the financial and investment portfolio of the UFS.

Candidates must be suitably qualified with requisite knowledge and experience of financial matters (including investments and acquisitions that are material to the UFS’s business). An appropriate qualification in the financial field is required, as is registration with the relevant professional bodies. 

Nominations must be submitted on the prescribed Nomination form, together with detailed curricula vitae, to the Registrar of the UFS at registrar@ufs.ac.za before 16:30 on 12 January 2022.

The Nominations Committee of Council will consider all the nominations and make a recommendation to the Council, which will decide whether to co-opt any of the candidates. 

The Finance Committee meets at least four times per year, or more frequently as may be necessary. 

The Council may decide not to co-opt any of the candidates.  

For enquiries, you may contact Mr NN Ntsababa at registrar@ufs.ac.za or telephone number +27 51 401 3796.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept